Showing results (1-10 of 463) with videos related to
Sort By:
Pageof 47
Diabetes & Metabolism Journal|December 29, 2015
Autophagy: A Novel Therapeutic Target for Diabetic NephropathyShinji Kume, Daisuke KoyaCurrent Opinion in Nephrology and Hypertension|November 20, 2013
Role of sirtuins in kidney diseaseMunehiro Kitada, Shinji Kume, Daisuke KoyaNature Reviews. Endocrinology|May 21, 2009
SIRT1 and insulin resistanceFengxia Liang, Shinji Kume, Daisuke KoyaClinical and Experimental Nephrology|November 14, 2013
Interventions against nutrient-sensing pathways represent an emerging new therapeutic approach for diabetic nephropathyDaisuke Koya, Munehiro Kitada, Shinji Kume, et al.Biomed Research International|August 16, 2014
Role of nutrient-sensing signals in the pathogenesis of diabetic nephropathyShinji Kume, Daisuke Koya, Takashi Uzu, et al.Clinical and Experimental Nephrology|September 14, 2012
Autophagy: a novel therapeutic target for kidney diseasesShinji Kume, Takashi Uzu, Hiroshi Maegawa, et al.Diabetes|January 29, 2011
Resveratrol improves oxidative stress and protects against diabetic nephropathy through normalization of Mn-SOD dysfunction in AMPK/SIRT1-independent pathwayMunehiro Kitada, Shinji Kume, Noriko Imaizumi, et al.PPAR Research|March 12, 2009
Peroxisome proliferator-activated receptors in diabetic nephropathyShinji Kume, Takashi Uzu, Keiji Isshiki, et al.Endocrine, Metabolic & Immune Disorders Drug Targets|January 5, 2010
SIRT1, a calorie restriction mimetic, in a new therapeutic approach for type 2 diabetes mellitus and diabetic vascular complicationsShinji Kume, Takashi Uzu, Atsunori Kashiwagi, et al.Seminars in Nephrology|February 4, 2014
Autophagy: emerging therapeutic target for diabetic nephropathyShinji Kume, Kosuke Yamahara, Mako Yasuda, et al.Pageof 47